EMSN Stock Overview
Engages in the high performance polymers and specialty chemicals businesses in the United States, Europe, Asia, and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 3/6 |
| Past Performance | 3/6 |
| Financial Health | 5/6 |
| Dividends | 5/6 |
Rewards
Risk Analysis
No risks detected for EMSN from our risk checks.
My Notes
Capture your thoughts, links and company narrative
EMS-CHEMIE HOLDING AG Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CHF 608.50 |
| 52 Week High | CHF 785.00 |
| 52 Week Low | CHF 599.00 |
| Beta | 0.59 |
| 1 Month Change | -4.85% |
| 3 Month Change | -9.31% |
| 1 Year Change | -11.10% |
| 3 Year Change | -39.57% |
| 5 Year Change | -5.66% |
| Change since IPO | 1,618.93% |
Recent News & Updates
EMS-CHEMIE HOLDING (VTX:EMSN) May Have Issues Allocating Its Capital
Dec 19
Pinning Down EMS-CHEMIE HOLDING AG's (VTX:EMSN) P/E Is Difficult Right Now
Dec 01Estimating The Intrinsic Value Of EMS-CHEMIE HOLDING AG (VTX:EMSN)
Nov 13Is EMS-CHEMIE HOLDING (VTX:EMSN) A Risky Investment?
Sep 20Recent updates
EMS-CHEMIE HOLDING (VTX:EMSN) May Have Issues Allocating Its Capital
Dec 19Pinning Down EMS-CHEMIE HOLDING AG's (VTX:EMSN) P/E Is Difficult Right Now
Dec 01Estimating The Intrinsic Value Of EMS-CHEMIE HOLDING AG (VTX:EMSN)
Nov 13Is EMS-CHEMIE HOLDING (VTX:EMSN) A Risky Investment?
Sep 20Investors Could Be Concerned With EMS-CHEMIE HOLDING's (VTX:EMSN) Returns On Capital
Aug 29Estimating The Fair Value Of EMS-CHEMIE HOLDING AG (VTX:EMSN)
Aug 04EMS-CHEMIE HOLDING AG's (VTX:EMSN) Shareholders Might Be Looking For Exit
Jun 13Returns On Capital Signal Difficult Times Ahead For EMS-CHEMIE HOLDING (VTX:EMSN)
May 22We Think EMS-CHEMIE HOLDING (VTX:EMSN) Can Stay On Top Of Its Debt
Apr 07Estimating The Intrinsic Value Of EMS-CHEMIE HOLDING AG (VTX:EMSN)
Mar 20The Returns At EMS-CHEMIE HOLDING (VTX:EMSN) Aren't Growing
Feb 06EMS-CHEMIE HOLDING AG's (VTX:EMSN) Business Is Trailing The Market But Its Shares Aren't
Dec 26Shareholder Returns
| EMSN | CH Chemicals | CH Market | |
|---|---|---|---|
| 7D | -2.2% | -4.2% | -2.3% |
| 1Y | -11.1% | -8.8% | 0.7% |
Return vs Industry: EMSN underperformed the Swiss Chemicals industry which returned -8.8% over the past year.
Return vs Market: EMSN underperformed the Swiss Market which returned 0.7% over the past year.
Price Volatility
| EMSN volatility | |
|---|---|
| EMSN Average Weekly Movement | 2.1% |
| Chemicals Industry Average Movement | 2.7% |
| Market Average Movement | 3.2% |
| 10% most volatile stocks in CH Market | 7.4% |
| 10% least volatile stocks in CH Market | 1.6% |
Stable Share Price: EMSN has not had significant price volatility in the past 3 months compared to the Swiss market.
Volatility Over Time: EMSN's weekly volatility (2%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1936 | 2,771 | Magdalena Martullo-Blocher | www.ems-group.com |
EMS-CHEMIE HOLDING AG engages in the high performance polymers and specialty chemicals businesses in the United States, Europe, Asia, and internationally. The company’s High Performance Polymers segment is involved in the manufacture and supply of high-performance polyamide granulate. Its Specialty Chemicals segment develops, produces, and sells fibers, fusible adhesives, and adhesive yarns for technical and textile applications, powder coatings, and reactive diluents.
EMS-CHEMIE HOLDING AG Fundamentals Summary
| EMSN fundamental statistics | |
|---|---|
| Market cap | CHF 14.23b |
| Earnings (TTM) | CHF 461.53m |
| Revenue (TTM) | CHF 2.12b |
30.8x
P/E Ratio6.7x
P/S RatioIs EMSN overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| EMSN income statement (TTM) | |
|---|---|
| Revenue | CHF 2.12b |
| Cost of Revenue | CHF 1.23b |
| Gross Profit | CHF 883.80m |
| Other Expenses | CHF 422.27m |
| Earnings | CHF 461.53m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
Feb 07, 2025
| Earnings per share (EPS) | 19.73 |
| Gross Margin | 41.76% |
| Net Profit Margin | 21.81% |
| Debt/Equity Ratio | 1.1% |
How did EMSN perform over the long term?
See historical performance and comparisonDividends
2.6%
Current Dividend Yield65%
Payout RatioCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/22 01:06 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/06/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
EMS-CHEMIE HOLDING AG is covered by 17 analysts. 7 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Konstantin Wiechert | Baader Helvea Equity Research |
| Volker Bosse | Baader Helvea Equity Research |
| Aron Ceccarelli | Berenberg |